Genedrive PLC on Tuesday announced that its chief executive officer has departed from the company after less than a year in the role.

The Manchester-based point of care pharmacogenetic testing company said James Cheek, who was appointed as CEO in September last year, has left the company immediately by mutual agreement.

Further, Genedrive promoted Chief Scientific Officer Gino Miele to CEO. Miele has been with the company since 2011 and served as CSO since September.

Chair Ian Gilham said: ‘Gino has an unparallelled knowledge and understanding of the company, products and commercial strategies. I have every confidence that the leadership team, headed by Gino and strongly supported by our Chief Financial Officer, Russ Shaw, will lead genedrive to a successful future. I would like to thank James for his contributions at genedrive and, on behalf of the board, wish him well for the future.’

Genedrive shares fell 8.1% to 2.85 pence each on Tuesday afternoon in London.

Copyright 2024 Alliance News Ltd. All Rights Reserved.